You are here

  • Home
  • Archive
  • Volume 80, Issue 10
  • Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2

Article info

Article menu
Epidemiology
Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2

Authors

  • Yolanda Braun-Moscovici B. Shine Department of Rheumatology, Rambam Health Care Campus, Haifa, Israel The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel PubMed articlesGoogle scholar articles
  • Marielle Kaplan The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel Biochemistry Laboratory, Rambam Health Care Campus, Haifa, Israel PubMed articlesGoogle scholar articles
  • Maya Braun Bioinformatics, The Hebrew University of Jerusalem Faculty of Medicine, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Doron Markovits B. Shine Department of Rheumatology, Rambam Health Care Campus, Haifa, Israel The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel PubMed articlesGoogle scholar articles
  • Samy Giryes B. Shine Department of Rheumatology, Rambam Health Care Campus, Haifa, Israel The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel PubMed articlesGoogle scholar articles
  • Kohava Toledano B. Shine Department of Rheumatology, Rambam Health Care Campus, Haifa, Israel The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel PubMed articlesGoogle scholar articles
  • Yonit Tavor B. Shine Department of Rheumatology, Rambam Health Care Campus, Haifa, Israel The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel PubMed articlesGoogle scholar articles
  • Katya Dolnikov B. Shine Department of Rheumatology, Rambam Health Care Campus, Haifa, Israel The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel PubMed articlesGoogle scholar articles
  • Alexandra Balbir-Gurman B. Shine Department of Rheumatology, Rambam Health Care Campus, Haifa, Israel The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yolanda Braun-Moscovici, B. Shine Department of Rheumatology, Rambam Health Care Campus, Haifa 31096, Israel; y_braun{at}rambam.health.gov.il
View Full Text

Citation

Braun-Moscovici Y, Kaplan M, Braun M, et al
Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
Annals of the Rheumatic Diseases 2021;80:1317-1321.

Publication history

  • Received April 4, 2021
  • Accepted June 4, 2021
  • First published June 18, 2021.
Online issue publication 
January 10, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage